Filing Details
- Accession Number:
- 0001179110-22-000397
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-11 16:18:07
- Reporting Period:
- 2022-01-07
- Accepted Time:
- 2022-01-11 16:18:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1808968 | B. Matthew Klein | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-01-07 | 775 | $38.53 | 16,461 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-01-07 | 21,000 | $0.00 | 37,461 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2022-01-07 | 20,000 | $0.00 | 57,461 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2022-01-07 | 52,500 | $0.00 | 52,500 | $38.10 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2022-01-07 | 50,000 | $0.00 | 50,000 | $38.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 52,500 | 2032-01-06 | No | 4 | A | Direct | |
| 50,000 | 2032-01-06 | No | 4 | A | Direct |
Footnotes
- Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,250 RSUs from a January 6, 2021 grant of 9,000 RSUs.
- Includes 203 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2021 and 224 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2021.
- Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
- Restricted stock units granted on January 7, 2022 that vest in two equal installments over two years, commencing on January 7, 2023.
- This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.
- This option was granted on January 7, 2022 and vests in two equal installments over two years, commencing on January 7, 2023.
Billionaire Hedge Funds
